BLMN
Bloomin' Brands, Inc.
BLMN has the edge over GME overall, supported by stronger modeled upside and lower modeled downside.
GME
GameStop Corp.
GME offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BLMN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
BLMN's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
BLMN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.3x | $10.12 | — |
| Cheap | 9.8x | $8.08 | -20% |
| Current | 12x | $10.12 | — |
| Fair | 22x | $18.19 | +80% |
| Expensive | 34x | $27.95 | +176% |
Historical ranges are pointers, not guarantees.
BLMN's PE is in its cheap range at 12x. If earnings grow as analysts expect, today's price would be 9.3x next year's earnings.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME has the edge over BLMN in the historical PE scenario, which offers more potential upside but is not a forecast.
BLMN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| Low |
BLMN has the edge over GME on the outlook, with more favorable valuation and earnings expectations.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
BLMN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.09 | +33% |
| Q3 2026 | $0.82 | +$1.49 |
| Q2 2026 | $0.31 | +$0.36 |
| Q1 2026 | $0.25 | +$0.28 |
| Q4 2025 | $0.10 | +$1.59 |
| Q3 2025 | -$0.67 | -$0.59 |
| Q2 2025 | -$0.05 | -117% |
| Q1 2025 | -$0.03 | -104% |
| Q4 2024 | -$1.49 | -158% |
BLMN has returned to profit: it earned $0.82 per share over the past year, after losing money the year before.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME has the edge over BLMN on earnings, with more consistent year-over-year improvement.
BLMN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $944.3M | +1.7% |
| Q2 2026 | $1B | +1.3% |
| Q1 2026 | $1.1B | +1% |
| Q4 2025 | $975.2M | +0.3% |
| Q3 2025 | $928.8M | -11% |
| Q2 2025 | $1B | -10% |
| Q1 2025 | $1B | -12% |
| Q4 2024 | $972M | -19% |
BLMN has the edge over GME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2% | +5.9 points |
| Q2 2026 | 3.8% | +0.8 points |
| Q1 2026 | 5.6% | +0.1 points |
| Q4 2025 | -1.4% | -3 points |
| Q3 2025 | -3.9% | -5.6 points |
| Q2 2025 | 3% | -1.2 points |
| Q1 2025 | 5.5% | -1 points |
| Q4 2024 | 1.7% | -3.1 points |
BLMN's operating margin was 2% last quarter, up 5.9 points from the same quarter a year ago.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME has the edge over BLMN on profitability, with a higher operating margin.
BLMN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$39.2M | -$33.5M |
| Q2 2026 | $46.9M | +321% |
| Q1 2026 | $50.1M | +81% |
| Q4 2025 | $63.7M | -35% |
| Q3 2025 | -$5.7M | +$69.2M |
| Q2 2025 | $11.1M | +$35.4M |
| Q1 2025 | $27.7M | +211% |
| Q4 2024 | $97.7M | +58% |
BLMN usually generates cash, though not every quarter: the latest was −$39M, but it generated $121M over the past year.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME has the edge over BLMN on cash flow, with more consistent year-over-year improvement.
BLMN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -587K shares |
| 1 year | +0.6% | +543K shares |
| 3 years | -13% | -12.9M shares |
| 5 years | -21% | -22.1M shares |
| Available history | -4.6% | -4.1M shares |
BLMN has the edge over GME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $18.2M |
| Q2 2024 | $14.6M |
| Q1 2024 | $232.9M |
GME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +300K shares |
| 1 year | +8.4% | +46.1M shares |
| 3 years | +94% | +288M shares |
| 5 years | +104% | +302M shares |
| Available history | +80% | +264M shares |
GME has 593M diluted shares, up 8.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | $21.8M |
| Q4 2019 | $114M |
BLMN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.4x | Moderate |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q2 2025 | 3.0x | Elevated |
| Q1 2025 | 2.8x | Moderate |
| Q4 2024 | 2.9x | Moderate |
BLMN's net debt is about 2.4 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
GME Net Leverage
BLMN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.2 | Neutral |
| Stochastic | 53.6 | Neutral |
BLMN's weekly RSI is 56 (neutral) and its Stochastic is 54 (neutral).
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
BLMN PE vs Consumer Cyclical Sector
| Metric | BLMN | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 32% below |
| PE % | 31 | 47 | 16 pts below |
BLMN has the edge over GME on valuation relative to its sector.
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
BLMN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.32 | 8.6% above |
| 20 week MA | $9.35 | 8.2% above |
| 50 week MA | $7.86 | 29% above |
| 100 week MA | $8.25 | 23% above |
| 200 week MA | $15.7 | 36% below |
BLMN has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 36% below its 200-week average.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME has the edge over BLMN on trend strength, trading above more of its moving averages.
BLMN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.7 | $19.0 | -13% |
| 2021 | $19.0 | $21.0 | +11% |
| 2022 | $21.0 | $21.0 | 0% |
| 2023 | $21.0 | $28.2 | +34% |
| 2024 | $28.2 | $12.3 | -56% |
| 2025 | $12.3 | $6.79 | -45% |
| 2026 YTD | $6.79 | $10.1 | +49% |
BLMN has the edge over GME on returns for 2026, with the stronger performance.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME's yearly returns have swung widely, from +655% in 2021 to −47% in 2022. It's up 21% so far in 2026.